Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cipepofol vs propofol for anesthesia in post-CABG deep sternal wound debridement
ChiCTR2600129356Phase 4Not yet recruiting
- Sponsor
- Beijing Aerospace General Hospital
- Start
- Aug 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Deep sternal wound infection (DSWI) comparing Group C (cipepofol) with Group P (propofol) (2 arms). Primary endpoint: Area under the curve of mean arterial pressure change within 10 minutes after induction. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
Deep sternal wound infection (DSWI)
Beyond the preview
Go deeper on ChiCTR2600129356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129356.